Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Theravance Biopharma, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- −12 vs. Q2 2024
- Shares held
- 45.8M
- +2.44M (+5.6%) vs. Q2 2024
- Total value
- $368.9M
- +$1.47M (+0.4%) vs. Q2 2024
- New holders
- 13
- 40 more added
- Sold out
- 25
- 42 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 179 | $817.5M |
| Q1 2026 | 173 | $814.2M |
| Q4 2025 | 169 | $927.2M |
| Q3 2025 | 161 | $706.3M |
| Q2 2025 | 135 | $512.2M |
| Q1 2025 | 132 | $400.9M |
| Q4 2024 | 128 | $422.4M |
| Q3 2024 | 119 | $368.9M |
| Q2 2024 | 132 | $399.5M |
| Q1 2024 | 121 | $430.6M |
| Q4 2023 | 118 | $548.7M |
| Q3 2023 | 115 | $438.5M |
| Q2 2023 | 119 | $546.3M |
| Q1 2023 | 114 | $652.6M |
| Q4 2022 | 119 | $696.1M |
| Q3 2022 | 123 | $649.8M |
| Q2 2022 | 113 | $582.0M |
| Q1 2022 | 121 | $602.5M |
| Q4 2021 | 116 | $655.6M |
| Q3 2021 | 119 | $448.8M |
| Q2 2021 | 109 | $883.1M |
| Q1 2021 | 107 | $1.09B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Theravance Biopharma, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 383,782 | $3.09M | 0.00% | −81,185−17.5% | Reduced |
| Nuveen Asset Management, LLC | 447,092 | $3.60M | 0.00% | +104,377+30.5% | Added |
| Dimensional Fund Advisors LP | 458,409 | $3.69M | 0.00% | +128,228+38.8% | Added |
| Bank of America Corp | 468,879 | $3.78M | 0.00% | −7,290−1.5% | Reduced |
| Morgan Stanley | 495,813 | $4.00M | 0.00% | +36,890+8.0% | Added |
| Jacobs Levy Equity Management, Inc | 576,447 | $4.65M | 0.02% | −10,167−1.7% | Reduced |
| Pictet Asset Management Holding SA | 684,892 | $5.55M | 0.01% | −193,763−22.1% | Reduced |
| D. E. Shaw & Co., Inc. | 764,765 | $6.16M | 0.01% | +6,685+0.9% | Added |
| Geode Capital Management, LLC | 857,979 | $6.92M | 0.00% | +593+0.1% | Added |
| Camber Capital Management LP | 1,000,000 | $8.06M | 0.31% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 1,115,765 | $8.99M | 3.29% | −42,200−3.6% | Reduced |
| State Street Corp | 1,191,621 | $9.60M | 0.00% | −75,754−6.0% | Reduced |
| Park West Asset Management LLC | 1,862,988 | $15.0M | 1.11% | +162,988+9.6% | Added |
| Vanguard Group Inc | 2,051,689 | $16.5M | 0.00% | +49,510+2.5% | Added |
| Irenic Capital Management LP | 2,760,948 | $22.3M | 3.90% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,731,305 | $30.1M | 0.00% | +3,731,305 | New |
| Newtyn Management, LLC | 4,499,066 | $36.3M | 5.57% | +2,374,363+111.8% | Added |
| Weiss Asset Management LP | 7,457,060 | $60.1M | 1.53% | 00.0% | Unchanged |
| Madison Avenue Partners, LP | 9,511,150 | $76.7M | 7.11% | +999,800+11.7% | Added |
| Baupost Group LLCSuperinvestorBaupost Group | 0 | $0 | 0.00% | −4,200,021−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −160,138−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −153,424−100.0% | Sold out |
| Chescapmanager LLC | 0 | $0 | 0.00% | −96,197−100.0% | Sold out |
| Petrus Trust Company, LTA | 0 | $0 | 0.00% | −81,449−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −49,523−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −44,180−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −39,526−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −34,107−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −33,900−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −33,760−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −18,154−100.0% | Sold out |
| Inceptionr LLC | 0 | $0 | 0.00% | −17,435−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −16,023−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −12,829−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −12,139−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −10,849−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −9,057−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,824−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −285−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −186−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |